Table of Content


1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Ligase Market
5. Voice of Customer
6. Global Ligase Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Quick Ligase, T4 DNA Ligase, E.Coli DNA Ligase, T4 RNA Ligase, Others)
6.2.2. By Source (Archaebacterium, Escherichia coli, Thermus thermophilus, Others)
6.2.3. By Application (Ligase Chain Reaction, Ligase Detection Reaction, Next Generation Sequencing, Molecular Cloning, Others)
6.2.4. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)
6.2.5. By Region
6.2.6. By Company (2021)
6.3. Market Map
7. North America Ligase Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Source
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States Ligase Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Source
7.3.1.2.3. By Application
7.3.1.2.4. By End User
7.3.2. Mexico Ligase Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Source
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3. Canada Ligase Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Source
7.3.3.2.3. By Application
7.3.3.2.4. By End User
8. Europe Ligase Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Source
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. France Ligase Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Source
8.3.1.2.3. By Application
8.3.1.2.4. By End User
8.3.2. Germany Ligase Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Source
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8.3.3. United Kingdom Ligase Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Source
8.3.3.2.3. By Application
8.3.3.2.4. By End User
8.3.4. Italy Ligase Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Source
8.3.4.2.3. By Application
8.3.4.2.4. By End User
8.3.5. Spain Ligase Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Source
8.3.5.2.3. By Application
8.3.5.2.4. By End User
9. Asia-Pacific Ligase Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Source
9.2.3. By Application
9.2.4. By End User
9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Ligase Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Source
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9.3.2. India Ligase Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Source
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3. Japan Ligase Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Source
9.3.3.2.3. By Application
9.3.3.2.4. By End User
9.3.4. South Korea Ligase Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Product
9.3.4.2.2. By Source
9.3.4.2.3. By Application
9.3.4.2.4. By End User
9.3.5. Australia Ligase Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Product
9.3.5.2.2. By Source
9.3.5.2.3. By Application
9.3.5.2.4. By End User
10. South America Ligase Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Source
10.2.3. By Application
10.2.4. By End User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Ligase Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Source
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2. Argentina Ligase Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Source
10.3.2.2.3. By Application
10.3.2.2.4. By End User
10.3.3. Colombia Ligase Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Source
10.3.3.2.3. By Application
10.3.3.2.4. By End User
11. Middle East and Africa Ligase Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Source
11.2.3. By Application
11.2.4. By End User
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Ligase Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product
11.3.1.2.2. By Source
11.3.1.2.3. By Application
11.3.1.2.4. By End User
11.3.2. Saudi Arabia Ligase Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product
11.3.2.2.2. By Source
11.3.2.2.3. By Application
11.3.2.2.4. By End User
11.3.3. UAE Ligase Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product
11.3.3.2.2. By Source
11.3.3.2.3. By Application
11.3.3.2.4. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Bio-Rad Laboratories, Inc.
14.2. Agilent Technologies, Inc.
14.3. Codexis, Inc.
14.4. F. Hoffmann-La Roche AG
14.5. Merck KGaA
14.6. Promega Corporation
14.7. QIAGEN N.V.
14.8. ArcticZymes Technologies ASA
14.9. Thermo Fisher Scientific, Inc.
14.10. Takara Bio Inc.
15. Strategic Recommendations